Venture capital investment in U.S. life sciences companies soared 29 percent in 2014 from the year before, reaching $8.6 billion, the highest level since 2007. And there is reason to think 2015 will also be a big year for a sector having its third boom of the last two decades.
{iframe}http://www.technologyreview.com/news/535301/venture-capitalists-love-biotech-right-now/{/iframe}